ArticleOncology letters2025

Efficacy and safety outcomes of emerging EGFR‑TKIs for patients with non‑small cell lung cancer with EGFR exon 20 insertion mutations: A systematic review and meta‑analysis.

Kang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.